Fundraising FoxHealthtech Startups
18,778 companies tagged Healthtech, with their investors and founders.
0 investors
0 investors
0 investors
Surround Care is a healthcare holding company formed from Navvis and Esse Health that partners with health systems, health plans, and physician enterprises on population health and value-based care. Operating in the United States, it builds an integrated solution ecosystem aimed at value-based primary care delivery.
0 investors
0 investors
Sus Clinicals provides preclinical testing services using its Oncopig cancer model, a large-animal platform that induces tumors and other diseases on demand to generate predictive data for medical devices, drugs, and diagnostics. It serves healthcare and therapeutics developers seeking to accelerate drug and device development toward clinical trials.
0 investors
Vaxcyte is a biotech company developing vaccines to treat or prevent serious infectious diseases. The company is led by experienced vaccinologists and pharma industry veterans.
0 investors
0 investors
Swallow Solutions develops products for people with dysphagia (difficulty swallowing), offering specially formulated beverages and desserts to meet hydration and nutrition needs and reduce choking risk, as well as medical devices for oropharyngeal strengthening therapy. Its offerings are based on clinical research into the diagnosis and treatment of swallowing disorders.
0 investors
0 investors
0 investors
0 investors
Switch Healthcare is a Health Value Organization (HVO) that aims to help employers improve healthcare outcomes and control costs for their companies and employees, positioning itself as an alternative to conventional healthcare vendors and benefit advisors. It targets company leaders such as CEOs and CFOs and references an Alpha Trial and a white paper on health value.
0 investors
0 investors
0 investors
SymbioCellTech develops a cell therapy called "Neo-Islets" intended to treat Type 1 Diabetes without daily insulin injections or immunosuppressive anti-rejection drugs. The company targets the estimated 16 million people living with Type 1 Diabetes.
0 investors
SymKardia develops a selective cardiac neuromodulation therapy to treat cardiac arrhythmias such as atrial fibrillation, targeting the nervous system rather than only cardiac tissue. It is a clinical-stage cardiovascular medical device company running pre-clinical and clinical research programs.
0 investors
0 investors
0 investors
Synapse Health manages the operational, administrative, and financial complexity of durable medical equipment (DME) for patients, prescribers, DME providers, and health plans. Through its InHome, Equip, and Patient Portal products, it coordinates DME intake, documentation, fulfillment, and support across the US, including for skilled nursing facilities and hospice.
0 investors
0 investors
0 investors
Syncromune develops SYNC-T, an investigational in situ personalized combination immunotherapy platform designed to treat metastatic solid tumors by synchronizing patient-specific tumor antigens with immune modulatory biologics. The company's lead candidate, SV-102, is in Phase 2 clinical trials for metastatic castration-resistant prostate cancer.
0 investors
Synedgen develops first-in-class glycomics-based regenerative therapeutics that repair mucosal injury and restore barrier function. Its lead asset, MIIST305, is an orally delivered therapeutic that repairs gastrointestinal mucosal injury and reduces inflammation.
0 investors